Lingfeng Tong

858 total citations
11 papers, 229 citations indexed

About

Lingfeng Tong is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Lingfeng Tong has authored 11 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Physiology. Recurrent topics in Lingfeng Tong's work include Cancer, Hypoxia, and Metabolism (4 papers), Metabolism, Diabetes, and Cancer (4 papers) and Cholesterol and Lipid Metabolism (2 papers). Lingfeng Tong is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Metabolism, Diabetes, and Cancer (4 papers) and Cholesterol and Lipid Metabolism (2 papers). Lingfeng Tong collaborates with scholars based in China, Thailand and United States. Lingfeng Tong's co-authors include Xuemei Tong, Yakui Li, Ying Lu, Ming Feng, Lifang Wu, Yemin Zhu, Tian‐Le Xu, Na Tian, Jason G. Williams and Juan Liu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Research.

In The Last Decade

Lingfeng Tong

10 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lingfeng Tong China	6	145	90	32	31	23	11	229
Qingfei Meng China	8	187 1.3×	135 1.5×	33 1.0×	33 1.1×	16 0.7×	12	305
Honglan Zhou China	8	192 1.3×	130 1.4×	34 1.1×	29 0.9×	14 0.6×	17	316
Christina Blücher Germany	6	146 1.0×	109 1.2×	38 1.2×	59 1.9×	15 0.7×	8	276
Anna M. Westermark United States	4	181 1.2×	166 1.8×	69 2.2×	30 1.0×	20 0.9×	4	288
Daniel Mathow Germany	9	174 1.2×	46 0.5×	27 0.8×	44 1.4×	15 0.7×	11	348
Qianmei Yang China	7	180 1.2×	71 0.8×	23 0.7×	48 1.5×	28 1.2×	11	294
Hyun Je Kang South Korea	11	172 1.2×	51 0.6×	23 0.7×	41 1.3×	21 0.9×	14	297
Tatiana Konovalova Germany	9	236 1.6×	68 0.8×	39 1.2×	30 1.0×	23 1.0×	12	353
Lingyan Yuan China	10	257 1.8×	142 1.6×	25 0.8×	24 0.8×	17 0.7×	15	368
Yukihiro Hirata Japan	8	181 1.2×	86 1.0×	20 0.6×	67 2.2×	23 1.0×	12	336

Countries citing papers authored by Lingfeng Tong

Since Specialization

Citations

This map shows the geographic impact of Lingfeng Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfeng Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfeng Tong more than expected).

Fields of papers citing papers by Lingfeng Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfeng Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfeng Tong. The network helps show where Lingfeng Tong may publish in the future.

Co-authorship network of co-authors of Lingfeng Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfeng Tong. A scholar is included among the top collaborators of Lingfeng Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfeng Tong. Lingfeng Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Yan, Weijie, Lingfeng Tong, Jie Yang, et al.. (2025). Metabolic Reprogramming: A Crucial Contributor to Anticancer Drug Resistance. MedComm. 6(9). e70358–e70358.

Tong, Lingfeng, et al.. (2022). The Synthesis of 5-Hydroxybenzofurans via Tandem In Situ Oxidative Coupling and Cyclization. SynOpen. 6(3). 158–163. 1 indexed citations

Wang, Zhiyan, Sha Hua, Wenbo Yang, et al.. (2022). Nuclear Tkt promotes ischemic heart failure via the cleaved Parp1/Aif axis. Basic Research in Cardiology. 117(1). 18–18. 16 indexed citations

Liu, Wei, Yemin Zhu, Yakui Li, et al.. (2022). Loss of transketolase promotes the anti-diabetic role of brown adipose tissues. Journal of Endocrinology. 256(3). 1 indexed citations

Zhu, Yemin, Yu Luan, Lifang Wu, et al.. (2022). MEK1‐dependent MondoA phosphorylation regulates glucose uptake in response to ketone bodies in colorectal cancer cells. Cancer Science. 114(3). 961–975. 3 indexed citations

Tian, Na, Hu Lei, Ying Lu, et al.. (2021). TKT maintains intestinal ATP production and inhibits apoptosis-induced colitis. Cell Death and Disease. 12(10). 853–853. 26 indexed citations

Lu, Ying, Na Tian, Hu Lei, et al.. (2021). ERα down‐regulates carbohydrate responsive element binding protein and decreases aerobic glycolysis in liver cancer cells. Journal of Cellular and Molecular Medicine. 25(7). 3427–3436. 4 indexed citations

Xu, Qing, Yuanyuan Li, Xia Gao, et al.. (2020). HNF4α regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer. Nature Communications. 11(1). 3978–3978. 78 indexed citations

Tian, Na, Qi Liu, Yakui Li, et al.. (2020). Transketolase Deficiency in Adipose Tissues Protects Mice From Diet-Induced Obesity by Promoting Lipolysis. Diabetes. 69(7). 1355–1367. 26 indexed citations

10.

Li, Minle, Ying Lu, Yakui Li, et al.. (2019). Transketolase Deficiency Protects the Liver from DNA Damage by Increasing Levels of Ribose 5-Phosphate and Nucleotides. Cancer Research. 79(14). 3689–3701. 43 indexed citations

11.

Li, Yakui, Na Tian, Ping Zhang, et al.. (2019). The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation. Journal of Biological Chemistry. 294(40). 14745–14756. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact